Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Dec '24 Sep '24 Jun '24 Mar '24 Older periods
Piotroski F-Score
3 — — 2

+8 more TTM periods

ROE
153.11% (391.52%) (254.45%) (237.28%)
ROA
(23.11%) (71.70%) (72.97%) (84.95%)
ROIC
(0.51%) (9.84%) (16.32%) (41.26%)
Return on Tangible Assets
(69.91%) (316.75%) (293.34%) (263.92%)
Average Days of Receivables
142.65 236.84 277.22 296.30
Free Cash Flow per Share
(1.07) (1.50) (1.87) (2.18)
Free Cash Flow
(31.77) (44.79) (55.51) (64.62)
Other line items

Show all line items

Columns are period end dates